Global Industrial (NYSE:GIC) reported quarterly earnings of $0.35 per share which met the analyst consensus estimate. This is a 33.96 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $260.50 million which beat the analyst consensus estimate of $257.27 million by 1.26 percent. This is a 0.57 percent decrease over sales of $262.00 million the same period last year.
FDA OKs Pfizer’s New Bowel Disease Drug, Analysts Predict Peak Sales Of $3B A Year
The Food and Drug Administration (FDA) approved Pfizer Inc's (NYSE: PFE) Velsipity (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely active
